Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

92.30EUR
22 May 2015
Change (% chg)

€-0.08 (-0.09%)
Prev Close
€92.38
Open
€91.87
Day's High
€92.71
Day's Low
€91.82
Volume
2,013,267
Avg. Vol
3,043,827
52-wk High
€99.23
52-wk Low
€69.58

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer... (more)

Overall

Beta: 0.62
Market Cap(Mil.): €121,426.20
Shares Outstanding(Mil.): 1,314.63
Dividend: 2.85
Yield (%): 3.09

Financials

  SASY.PA Industry Sector
P/E (TTM): 28.50 37.08 39.09
EPS (TTM): 3.24 -- --
ROI: -- 16.21 15.55
ROE: -- 16.97 16.55
Search Stocks

Amgen first to win EU backing for new kind of cholesterol drug

- Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.

22 May 2015

Amgen first to win EU backing for new kind of cholesterol drug

May 22 - Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.

22 May 2015

Amgen cholesterol drug could get EU green light this week

LONDON - Amgen's new cholesterol drug Repatha could be recommended for approval in Europe as early as this week, putting it ahead in a race with a rival product from Sanofi.

19 May 2015

Amgen cholesterol drug could get EU green light this week

LONDON, May 19 - Amgen's new cholesterol drug Repatha could be recommended for approval in Europe as early as this week, putting it ahead in a race with a rival product from Sanofi.

19 May 2015

BRIEF-Evotec raises 2015 revenue guidance on Sanofi alliance

* Group EBITDA before contingent considerations at eur (0.3) m significantly improved compared to same period of previous year (2014: eur (1.3) m)

12 May 2015

UPDATE 1-Hedge fund firm Man Group feels investor backlash on pay

* Follows rebellions at companies from Sanofi to Barrick Gold (Adds detail from statement, quote from company)

08 May 2015

UPDATE 1-Sanofi rebels make mark in AGM vote on CEO pay

* Large shareholder minority votes against the pay packages (Adds detail on packages)

04 May 2015

Sanofi rebels make mark in AGM vote on CEO pay

PARIS, May 4 - Shareholders in drugs group Sanofi , which sacked its chief executive last year and appointed a new one in February, approved millions of euros in payments to both men on Monday despite a substantial rebellion by activist investors.

04 May 2015

RPT-Sanofi faces AGM row over cost of firing and hiring CEOs

PARIS, April 30 - Drugs group Sanofi, which sacked its chief executive last year and appointed a new one in February, has appealed for shareholder loyalty as it seeks to head off a potential rebellion over millions of euros in payments to both men.

01 May 2015

Sanofi faces AGM row over cost of firing and hiring CEOs

PARIS - Drugs group Sanofi, which sacked its chief executive last year and appointed a new one in February, has appealed for shareholder loyalty as it seeks to head off a potential rebellion over millions of euros in payments to both men.

30 Apr 2015

Earnings vs. Estimates

Search Stocks